Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ZIMV 
ZimVie Inc (ZIMV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: ZIMV (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $19
1 Year Target Price $19
| 1 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -16.13% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 535.72M USD | Price to earnings Ratio - | 1Y Target Price 19 |
Price to earnings Ratio - | 1Y Target Price 19 | ||
Volume (30-day avg) 4 | Beta 2.06 | 52 Weeks Range 8.15 - 19.01 | Updated Date 10/18/2025 |
52 Weeks Range 8.15 - 19.01 | Updated Date 10/18/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.69 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.39% | Operating Margin (TTM) 3.33% |
Management Effectiveness
Return on Assets (TTM) 0.51% | Return on Equity (TTM) -4.76% |
Valuation
Trailing PE - | Forward PE 22.22 | Enterprise Value 698675942 | Price to Sales(TTM) 1.21 |
Enterprise Value 698675942 | Price to Sales(TTM) 1.21 | ||
Enterprise Value to Revenue 1.58 | Enterprise Value to EBITDA 16.29 | Shares Outstanding 28210715 | Shares Floating 21657477 |
Shares Outstanding 28210715 | Shares Floating 21657477 | ||
Percent Insiders 2.73 | Percent Institutions 90.97 |
Upturn AI SWOT
ZimVie Inc
Company Overview
History and Background
ZimVie Inc. was founded in 2022 as a spin-off from Zimmer Biomet. This separation allowed Zimmer Biomet to focus on its core reconstruction business, while ZimVie aimed to concentrate on the dental and spine markets.
Core Business Areas
- Dental: Offers a comprehensive portfolio of dental implants, restorative solutions, and digital dentistry technologies. This includes implants, abutments, tools, and guided surgery systems.
- Spine: Provides a range of spine surgery solutions, including fusion and non-fusion therapies for treating various spinal conditions. These solutions include implants, biologics, and surgical instruments.
Leadership and Structure
Vafa Jamali serves as the President and CEO. The organizational structure is segmented based on the two core business areas (Dental and Spine), with supporting functions such as finance, operations, and marketing.
Top Products and Market Share
Key Offerings
- TSV Implants (Dental): TSV Implants are designed for immediate placement and loading, and is a premium implant solution. Market share data is not readily available, but competes with Nobel Biocare and Straumann. Estimated revenue is between $50 - $75M in the dental segment.
- Vitality Spinal Fixation System (Spine): A comprehensive system for spinal fusion, offering various rod materials and connection options. This is a flagship product within the spine segment. Competitors include Medtronic and Stryker. Estimated Revenue is between $75-100M.
Market Dynamics
Industry Overview
The dental and spine industries are experiencing growth driven by an aging population, increasing demand for minimally invasive procedures, and technological advancements in materials and surgical techniques.
Positioning
ZimVie aims to be a key player in the dental and spine markets by offering innovative solutions and focusing on specialized segments. The company faces competition from larger, more established players but seeks to differentiate through niche products and focused customer service.
Total Addressable Market (TAM)
The spine market is estimated at $10 billion and the dental implant market at $5 billion. ZimVie's positioning is to capture market share by offering differentiated technologies.
Upturn SWOT Analysis
Strengths
- Focus on Dental and Spine markets
- Innovative product portfolio
- Experienced management team
- Established distribution network
Weaknesses
- Smaller market capitalization compared to major competitors
- Recent spin-off, requires time to establish independent identity
- Lower brand recognition compared to established competitors
- High debt load following spin-off
Opportunities
- Expanding product offerings in growing markets
- Strategic acquisitions to broaden portfolio
- Partnerships to enhance distribution reach
- Adopting digital dentistry solutions
Threats
- Intense competition from larger players
- Regulatory hurdles and compliance requirements
- Pricing pressures and reimbursement challenges
- Economic downturn impacting elective surgery volumes
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- STR
- XRAY
- NUVA
Competitive Landscape
ZimVie is a smaller player facing intense competition from established giants. They need to focus on niche markets and innovative products to gain market share.
Growth Trajectory and Initiatives
Historical Growth: Growth has been modest since the spin-off as the company is focused on restructuring and streamlining operations.
Future Projections: Analysts expect revenue growth of around 3-5% in the next few years. Profitability and margin improvements are crucial for long-term success.
Recent Initiatives: Initiatives include focusing on faster growing product segments and cost management to improve financial performance.
Summary
ZimVie is a recently spun-off company operating in the dental and spine markets. It faces challenges from larger competitors and a high debt load, but has opportunities for growth through product innovation and market expansion. Profitability needs improvement. Long-term success depends on cost management, growth and successful implementation of strategic initiatives. The company needs to be aggressive to generate revenue in a highly competitive landscape
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Analyst Reports
- Industry Publications
- Company Website
Disclaimers:
This analysis is based on available information and represents an opinion. Actual results may vary. This is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ZimVie Inc
Exchange NASDAQ | Headquaters Palm Beach Gardens, FL, United States | ||
IPO Launch date 2022-03-01 | President, CEO & Chairman of the Board Mr. Vafa Jamali | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1770 | Website https://www.zimvie.com |
Full time employees 1770 | Website https://www.zimvie.com | ||
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including dental service organizations, as well as educational, medical and governmental entities, hospitals, and surgery centers through sales representatives, independent sales agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.